Trial Profile
Study of the effect of co-formulation of insulin degludec/insulin aspart in insulin-naïve patients.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Sep 2016
Price :
$35
*
At a glance
- Drugs Insulin degludec/insulin aspart (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 22 Sep 2016 New trial record